Errol M. Rudman’s Immunomedics Inc IMMU Stock Holding History

Errol M. Rudman’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-35,000	Closed	-$672K	–	25
2019 Q1	$672K	Buy	+35,000	New	+$564K	0.45%	26

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Errol M. Rudman's IMMU Position: Q2 2019 in Review

Errol M. Rudman sold out of Immunomedics Inc (IMMU) in Q2 2019, closing a stake of 35,000 shares — an estimated $672K sold.

Errol M. Rudman first reported a position in IMMU in Q1 2019 and held it in 1 quarter. The position peaked at $672K in Q1 2019. 204 funds tracked by Wall St. Rank hold IMMU as of Q2 2019.

Errol M. Rudman reported no remaining Immunomedics Inc position as of Q2 2019 after selling out during the quarter.
Errol M. Rudman sold 35,000 Immunomedics Inc shares in Q2 2019, an estimated $672K.
Errol M. Rudman first reported a position in Immunomedics Inc in Q1 2019 and held it in 1 quarter.
Errol M. Rudman's Immunomedics Inc position peaked at $672K in Q1 2019.
204 funds tracked by Wall St. Rank held Immunomedics Inc as of Q2 2019.

Based on Errol M. Rudman's 13F filing for Q2 2019.